Allogeneic	0	10	O
injection	11	20	O
of	21	23	O
fetal	24	29	B-Cell
membrane	30	38	I-Cell
-	38	39	I-Cell
derived	39	46	I-Cell
mesenchymal	47	58	I-Cell
stem	59	63	I-Cell
cells	64	69	I-Cell
induces	70	77	O
therapeutic	78	89	O
angiogenesis	90	102	O
in	103	105	O
a	106	107	O
rat	108	111	B-Organism
model	112	117	O
of	118	120	O
hind	121	125	B-Organism_subdivision
limb	126	130	I-Organism_subdivision
ischemia	131	139	O
.	139	140	O

Bone	142	146	B-Cell
marrow	147	153	I-Cell
-	153	154	I-Cell
derived	154	161	I-Cell
mesenchymal	162	173	I-Cell
stem	174	178	I-Cell
cells	179	184	I-Cell
(	185	186	O
BM	186	188	B-Cell
-	188	189	I-Cell
MSC	189	192	I-Cell
)	192	193	O
have	194	198	O
been	199	203	O
demonstrated	204	216	O
to	217	219	O
be	220	222	O
an	223	225	O
attractive	226	236	O
therapeutic	237	248	O
cell	249	253	B-Cell
source	254	260	O
for	261	264	O
tissue	265	271	B-Tissue
regeneration	272	284	O
and	285	288	O
repair	289	295	O
.	295	296	O

However	297	304	O
,	304	305	O
it	306	308	O
remains	309	316	O
unknown	317	324	O
whether	325	332	O
or	333	335	O
not	336	339	O
allogeneic	340	350	O
transplantation	351	366	O
of	367	369	O
mesenchymal	370	381	B-Cell
stem	382	386	I-Cell
cells	387	392	I-Cell
(	393	394	O
MSC	394	397	B-Cell
)	397	398	O
derived	399	406	O
from	407	411	O
fetal	412	417	B-Multi-tissue_structure
membranes	418	427	I-Multi-tissue_structure
(	428	429	O
FM	429	431	B-Multi-tissue_structure
)	431	432	O
,	432	433	O
which	434	439	O
are	440	443	O
generally	444	453	O
discarded	454	463	O
as	464	466	O
medical	467	474	O
waste	475	480	O
after	481	486	O
delivery	487	495	O
,	495	496	O
has	497	500	O
therapeutic	501	512	O
potential	513	522	O
.	522	523	O

FM	524	526	B-Cell
-	526	527	I-Cell
MSC	527	530	I-Cell
were	531	535	O
obtained	536	544	O
from	545	549	O
Lewis	550	555	O
rats	556	560	B-Organism
and	561	564	O
had	565	568	O
surface	569	576	O
antigen	577	584	O
expression	585	595	O
and	596	599	O
multipotent	600	611	O
potential	612	621	O
partly	622	628	O
similar	629	636	O
to	637	639	O
those	640	645	O
of	646	648	O
BM	649	651	B-Cell
-	651	652	I-Cell
MSC	652	655	I-Cell
.	655	656	O

Compared	657	665	O
with	666	670	O
BM	671	673	B-Cell
-	673	674	I-Cell
MSC	674	677	I-Cell
,	677	678	O
FM	679	681	B-Cell
-	681	682	I-Cell
MSC	682	685	I-Cell
secreted	686	694	O
a	695	696	O
comparable	697	707	O
amount	708	714	O
of	715	717	O
hepatocyte	718	728	B-Gene_or_gene_product
growth	729	735	I-Gene_or_gene_product
factor	736	742	I-Gene_or_gene_product
despite	743	750	O
a	751	752	O
small	753	758	O
amount	759	765	O
of	766	768	O
vascular	769	777	B-Gene_or_gene_product
endothelial	778	789	I-Gene_or_gene_product
growth	790	796	I-Gene_or_gene_product
factor	797	803	I-Gene_or_gene_product
.	803	804	O

FM	805	807	B-Cell
-	807	808	I-Cell
MSC	808	811	I-Cell
and	812	815	O
BM	816	818	B-Cell
-	818	819	I-Cell
MSC	819	822	I-Cell
both	823	827	O
expressed	828	837	O
major	838	843	O
histocompatibility	844	862	O
complex	863	870	O
(	871	872	O
MHC	872	875	O
)	875	876	O
class	877	882	O
I	883	884	O
but	885	888	O
not	889	892	O
MHC	893	896	O
class	897	902	O
II	903	905	O
antigens	906	914	O
and	915	918	O
did	919	922	O
not	923	926	O
elicit	927	933	O
allogeneic	934	944	O
lymphocyte	945	955	B-Cell
proliferation	956	969	O
in	970	972	O
mixed	973	978	O
lymphocyte	979	989	B-Cell
culture	990	997	O
.	997	998	O

FM	999	1001	B-Cell
-	1001	1002	I-Cell
MSC	1002	1005	I-Cell
or	1006	1008	O
BM	1009	1011	B-Cell
-	1011	1012	I-Cell
MSC	1012	1015	I-Cell
obtained	1016	1024	O
from	1025	1029	O
Lewis	1030	1035	O
rats	1036	1040	B-Organism
were	1041	1045	O
injected	1046	1054	O
into	1055	1059	O
a	1060	1061	O
MHC	1062	1065	O
-	1065	1066	O
mismatched	1066	1076	O
August	1077	1083	O
-	1083	1084	O
Copenhagen	1084	1094	O
-	1094	1095	O
Irish	1095	1100	O
rat	1101	1104	B-Organism
model	1105	1110	O
of	1111	1113	O
hind	1114	1118	B-Organism_subdivision
limb	1119	1123	I-Organism_subdivision
ischemia	1124	1132	O
.	1132	1133	O

Three	1134	1139	O
weeks	1140	1145	O
after	1146	1151	O
injection	1152	1161	O
,	1161	1162	O
blood	1163	1168	B-Organism_substance
perfusion	1169	1178	O
and	1179	1182	O
capillary	1183	1192	B-Tissue
density	1193	1200	O
were	1201	1205	O
significantly	1206	1219	O
higher	1220	1226	O
in	1227	1229	O
the	1230	1233	O
FM	1234	1236	B-Cell
-	1236	1237	I-Cell
MSC	1237	1240	I-Cell
and	1241	1244	O
BM	1245	1247	B-Cell
-	1247	1248	I-Cell
MSC	1248	1251	I-Cell
groups	1252	1258	O
than	1259	1263	O
in	1264	1266	O
the	1267	1270	O
phosphate	1271	1280	B-Drug_or_compound
-	1280	1281	I-Drug_or_compound
buffered	1281	1289	I-Drug_or_compound
saline	1290	1296	I-Drug_or_compound
group	1297	1302	O
,	1302	1303	O
and	1304	1307	O
allogeneic	1308	1318	O
FM	1319	1321	B-Cell
-	1321	1322	I-Cell
MSC	1322	1325	I-Cell
and	1326	1329	O
BM	1330	1332	B-Cell
-	1332	1333	I-Cell
MSC	1333	1336	I-Cell
were	1337	1341	O
still	1342	1347	O
observed	1348	1356	O
.	1356	1357	O

In	1358	1360	O
nonischemic	1361	1372	O
hind	1373	1377	B-Tissue
limb	1378	1382	I-Tissue
tissues	1383	1390	I-Tissue
,	1390	1391	O
allogeneic	1392	1402	O
FM	1403	1405	B-Cell
-	1405	1406	I-Cell
MSC	1406	1409	I-Cell
and	1410	1413	O
BM	1414	1416	B-Cell
-	1416	1417	I-Cell
MSC	1417	1420	I-Cell
injection	1421	1430	O
were	1431	1435	O
associated	1436	1446	O
with	1447	1451	O
a	1452	1453	O
comparatively	1454	1467	O
small	1468	1473	O
amount	1474	1480	O
of	1481	1483	O
T	1484	1485	B-Cell
lymphocyte	1486	1496	I-Cell
infiltration	1497	1509	O
,	1509	1510	O
compared	1511	1519	O
with	1520	1524	O
the	1525	1528	O
injection	1529	1538	O
of	1539	1541	O
allogeneic	1542	1552	O
splenic	1553	1560	B-Cell
lymphocytes	1561	1572	I-Cell
.	1572	1573	O

In	1574	1576	O
conclusion	1577	1587	O
,	1587	1588	O
allogeneic	1589	1599	O
FM	1600	1602	B-Cell
-	1602	1603	I-Cell
MSC	1603	1606	I-Cell
injection	1607	1616	O
did	1617	1620	O
not	1621	1624	O
elicit	1625	1631	O
a	1632	1633	O
lymphocyte	1634	1644	B-Cell
proliferative	1645	1658	O
response	1659	1667	O
and	1668	1671	O
provided	1672	1680	O
significant	1681	1692	O
improvement	1693	1704	O
in	1705	1707	O
a	1708	1709	O
rat	1710	1713	B-Organism
model	1714	1719	O
of	1720	1722	O
hind	1723	1727	B-Organism_subdivision
limb	1728	1732	I-Organism_subdivision
ischemia	1733	1741	O
,	1741	1742	O
comparable	1743	1753	O
to	1754	1756	O
the	1757	1760	O
response	1761	1769	O
to	1770	1772	O
BM	1773	1775	B-Cell
-	1775	1776	I-Cell
MSC	1776	1779	I-Cell
.	1779	1780	O

Thus	1781	1785	O
,	1785	1786	O
allogeneic	1787	1797	O
injection	1798	1807	O
of	1808	1810	O
FM	1811	1813	B-Cell
-	1813	1814	I-Cell
MSC	1814	1817	I-Cell
may	1818	1821	O
be	1822	1824	O
a	1825	1826	O
new	1827	1830	O
therapeutic	1831	1842	O
strategy	1843	1851	O
for	1852	1855	O
the	1856	1859	O
treatment	1860	1869	O
of	1870	1872	O
severe	1873	1879	O
peripheral	1880	1890	O
vascular	1891	1899	O
disease	1900	1907	O
.	1907	1908	O

Disclosure	1909	1919	O
of	1920	1922	O
potential	1923	1932	O
conflicts	1933	1942	O
of	1943	1945	O
interest	1946	1954	O
is	1955	1957	O
found	1958	1963	O
at	1964	1966	O
the	1967	1970	O
end	1971	1974	O
of	1975	1977	O
this	1978	1982	O
article	1983	1990	O
.	1990	1991	O

